Ovid Therapeutics, Inc. (OVID)
2.79
+0.06
(+2.20%)
USD |
NASDAQ |
May 08, 12:57
Ovid Therapeutics Research and Development Expense (Annual) : 25.38M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| PTC Therapeutics, Inc. | 455.25M |
| CytomX Therapeutics, Inc. | 65.80M |
| Artelo Biosciences, Inc. | 5.423M |
| Eton Pharmaceuticals, Inc. | 7.765M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |